Evidence map›Paper›PMID 41239798›Full record

SynthesisCentral nervous system agents in medicinal chemistry2025

Medicinal Plants in the Treatment of Tuberculosis: A Systematic Review.

Radha Agrawal, Yogesh Murti, Mohit Mangla, Mohit Sanduja, Anuj Kumar Sharma, Vibha Kumari, Mayank Kulshreshtha

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Central nervous system agents in medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Radha AgrawalRajiv Academy for Pharmacy, Mathura (Uttar Pradesh), India.
Yogesh MurtiInstitute of Pharmaceutical Research, GLA University, Mathura, India.
Mohit ManglaSchool of Medical & Allied Sciences, GD Goenka University, Gurugram (Haryana), India.
Mohit SandujaSchool of Medical & Allied Sciences, GD Goenka University, Gurugram (Haryana), India.
Anuj Kumar SharmaRajiv Academy for Pharmacy, Mathura (Uttar Pradesh), India.
Vibha KumariRajiv Academy for Pharmacy, Mathura (Uttar Pradesh), India.
Mayank KulshreshthaRajiv Academy for Pharmacy, Mathura (Uttar Pradesh), India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTuberculosis (TB) is the most common disease that affects the lungs, and it is associated with Mycobacterium tuberculosis infection. Many synthetic medications, such as pyrazinamide, isoniazid, and ethambutol, are available to treat TB; however, their adverse effects are severe. Medicinal herbs have lately become popular, safe, and effective alternative treatments for TB.

methodsThe purpose of this systematic review was to assess the possible use of natural plants in the development of herbal treatments and remedies for TB by studying the medicinal plants and phytochemicals that have been used for the disease. Information was gathered from a variety of sources, including Bentham, Elsevier, Springer, Nature, Google Scholar, PubMed, Sci- Finder, and the Web of Science. For the investigation, common and scientific names of plants, as well as terms like "mycobacterium tuberculosis," "herbal plants," "flavonoids," and "alkaloids" were employed. In the end, 376 plants belonging to 83 families were discovered, and details about each plant family, as well as the section of the plant utilized, chemical components, extract, and strain, were extracted.

resultsThe findings showed that although flavonoids and alkaloids were the most prevalent naturally occurring substances found in plants, the Fabiaceae family had a greater potential to eradicate TB.

conclusionThe leaf portion was shown to be more active, and the S-37 RV strain of Mycobacterium TB was employed more frequently.

Indexed as

Antitubercular AgentsPhytotherapyPlant ExtractsPlants, MedicinalTuberculosisAnimalsHumansMycobacterium tuberculosisAntitubercular AgentsPlant Extractsalkaloidsflavonoidsmethanolic extract.Mycobacterium tuberculosisnatural compoundsTuberculosis

Identifiers

PMID41239798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.